T1	intervention 49 87	silver carboxymethylcellulose dressing
T2	condition 91 115	surgical site infections
T3	age 576 585	≥18 years
T4	eligibility 587 665	diagnosed with breast cancer, undergoing breast conserving or ablative surgery
T5	outcome-Measure 830 856	SSI following CDC criteria
T6	total-participants 869 872	230
T7	intervention-participants 897 900	106
T8	control-participants 926 929	124
T9	control 930 938	controls
T10	iv-bin-abs 940 945	Seven
T11	iv-bin-percent 956 960	6.6%
T12	outcome 962 975	developed SSI
T13	cv-bin-abs 1001 1003	16
T14	cv-bin-percent 1014 1019	12.9%
T15	outcome 1237 1245	SSI rate
T16	iv-bin-abs 1250 1251	1
T17	intervention-participants 1252 1254	56
T18	iv-bin-percent 1256 1260	1.8%
T19	cv-bin-abs 1287 1288	7
T20	control-participants 1289 1291	65
T21	cv-bin-percent 1293 1298	10.8%
T22	outcome 1385 1405	patient satisfaction
T23	outcome 1469 1501	dressing changes within 48 hours
T24	outcome 1547 1560	re-operations
T25	iv-bin-percent 1562 1564	0%
T26	cv-bin-percent 1569 1573	3.2%
T28	outcome 1763 1794	attributable costs of SSI model
T31	iv-cont-median 1414 1415	8
T32	cv-cont-median 1420 1421	7
T35	iv-cont-mean 1649 1656	€265.42
T36	cv-cont-mean 1672 1679	€470.65
T37	iv-cont-mean 1712 1718	€59.12
T38	cv-cont-mean 1734 1740	€67.55
T29	iv-cont-sd 1663 1666	908
T30	cv-cont-sd 1686 1690	1223
T33	iv-cont-sd 1725 1728	129
T34	cv-cont-sd 1747 1750	172
T27	outcome 1597 1631	mean wound-related treatment costs
